Aflatoxin B1-induced DNA adduct formation in murine kidney and liver

IF 4.2 3区环境科学与生态学 Q2 ENVIRONMENTAL SCIENCES

Environmental toxicology and pharmacology Pub Date : 2025-01-28 DOI:10.1016/j.etap.2025.104647

Pawel Jaruga , Vladimir L. Vartanian , Irina G. Minko , Miral Dizdaroglu , R. Stephen Lloyd

{"title":"Aflatoxin B1-induced DNA adduct formation in murine kidney and liver","authors":"Pawel Jaruga , Vladimir L. Vartanian , Irina G. Minko , Miral Dizdaroglu , R. Stephen Lloyd","doi":"10.1016/j.etap.2025.104647","DOIUrl":null,"url":null,"abstract":"<div><div>Aflatoxicosis is a life-threatening nephrotoxic condition arising from eating foods highly contaminated with aflatoxin-producing molds. Additionally, chronic aflatoxin exposures are linked to enhanced hepatocellular carcinomas. Using recent advances in mass spectrometry for the detection of aflatoxin B<sub>1</sub> (AFB<sub>1</sub>) DNA adducts, we present data which show generation of these adducts in the kidney, albeit at ≈ 100-fold lower levels than in the liver of the same animal. This result is consistent with tissue-specific differences in the expression of cytochrome P450s implicated in the activation of AFB<sub>1</sub>. Although the mechanisms underlying aflatoxin-induced nephrotoxicity had been postulated to be driven by the generation of high levels of reactive oxygen species, measurement of oxidatively-induced DNA base damage did not reveal evidence for genotoxic induction of these lesions. Overall, this investigation provides evidence of the formation of aflatoxin-specific adducts in kidney tissue and challenges the hypothesis of acute aflatoxin exposures generating reactive oxygen-mediated DNA damage.</div></div>","PeriodicalId":11775,"journal":{"name":"Environmental toxicology and pharmacology","volume":"114 ","pages":"Article 104647"},"PeriodicalIF":4.2000,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Environmental toxicology and pharmacology","FirstCategoryId":"93","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1382668925000225","RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}

引用次数: 0

Abstract

Aflatoxicosis is a life-threatening nephrotoxic condition arising from eating foods highly contaminated with aflatoxin-producing molds. Additionally, chronic aflatoxin exposures are linked to enhanced hepatocellular carcinomas. Using recent advances in mass spectrometry for the detection of aflatoxin B₁ (AFB₁) DNA adducts, we present data which show generation of these adducts in the kidney, albeit at ≈ 100-fold lower levels than in the liver of the same animal. This result is consistent with tissue-specific differences in the expression of cytochrome P450s implicated in the activation of AFB₁. Although the mechanisms underlying aflatoxin-induced nephrotoxicity had been postulated to be driven by the generation of high levels of reactive oxygen species, measurement of oxidatively-induced DNA base damage did not reveal evidence for genotoxic induction of these lesions. Overall, this investigation provides evidence of the formation of aflatoxin-specific adducts in kidney tissue and challenges the hypothesis of acute aflatoxin exposures generating reactive oxygen-mediated DNA damage.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Environmental toxicology and pharmacology 医学-毒理学

CiteScore

7.00

自引率

4.70%

发文量

185

审稿时长

34 days

期刊介绍： Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man. Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals. In addition to full length papers, short communications, full-length reviews and mini-reviews, Environmental Toxicology and Pharmacology will publish in depth assessments of special problem areas. The latter publications may exceed the length of a full length paper three to fourfold. A basic requirement is that the assessments are made under the auspices of international groups of leading experts in the fields concerned. The information examined may either consist of data that were already published, or of new data that were obtained within the framework of collaborative research programmes. Provision is also made for the acceptance of minireviews on (classes of) compounds, toxicities or mechanisms, debating recent advances in rapidly developing fields that fall within the scope of the journal.